Company & Sponsor Intelligence

Xuanwu Hospital, Beijing

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials11

Recruiting7

Completed0

Countries1

Therapeutic footprint

epilepsymultiple_sclerosispain_neuropathyparkinsonsstroke

Indexed studies

NCT06558864High Selective Subiculum SEEG Guided RF-TC for mTLE-HS
epilepsy · NA

NCT03025906Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus
epilepsy · ChinaPHASE2

NCT06942611Transcranial Electrical Stimulation for Treating Chronic Pain in Inflammatory Demyelinating Diseases
multiple_sclerosis · ChinaNA

NCT06344338Application of tDCS Stimulation in Controlling Refractory Status Epilepticus
epilepsy · ChinaNA

NCT01416818Treatment of Depression in Parkinson's Disease
parkinsons · ChinaPHASE2

NCT06436547Subiculum Electrical Stimulation for Temporal Lobe Epilepsy With Biliteral Hippocampus Sclerosis(SESTB)
epilepsy · ChinaNA

NCT07566663Preventive Analgesia With Anrikefon in Laparoscopic Cholecystectomy
pain_neuropathy · ChinaNA

NCT02021825Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders
multiple_sclerosis · ChinaPHASE4

NCT03256513The Safety and Efficacy of Peri-procedure Blood Pressure Management of Revascularization
stroke · ChinaNA

NCT06524479Investigating the Functional Characteristics During Wakefulness and Sleep Based on SEEG
epilepsy · ChinaNA

NCT07602205Efficacy and Safety of Daily Home-based Hyperthermic Baths for Reducing Epileptic Seizures in CDKL5 Deficiency Disorder: A PROBE Clinical Trial
epilepsy · NA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →